i

indee labs (YC W17)

5 employees

Indee Labs is unlocking gene-modified cell therapy for the masses with scalable hardware for gene delivery.

Basic info

Industry

biotechnology research

Sectors

Cellular Engineering
Biotechnology
Gene Therapy
Medical Devices
Gene Editing
Intracellular Delivery
Genetic Engineering
Transfection
Immunotherapy
Cell-derived Gene Therapy
Genetics
Manufacturing
T Cell Immunotherapy
T Cell Manufacturing
Microfluidics
Non-Viral Delivery

Date founded

2015

Funding rounds raised

Total raised

$2.6M

from 12 investors over 12 rounds

i

indee labs (YC W17) raised undisclosed on June 6, 2023

Investors: BioTools Innovator

i

indee labs (YC W17) raised undisclosed on September 23, 2021

Investors: IndieBio and SOSV - The Accelerator VC

i

indee labs (YC W17) raised undisclosed on November 2, 2020

Investors: Endpoint Ventures

i

indee labs (YC W17) raised undisclosed on August 24, 2020

Investors: National Institute of Allergy and Infectious Diseases (NIAID)

i

indee labs (YC W17) raised $2.6M on May 17, 2018

Investors: Founders Fund and Main Sequence Ventures

i

indee labs (YC W17) raised $692K on April 18, 2018

Investors: MTPConnect

i

indee labs (YC W17) raised $1.3M on July 3, 2017

Investors: IndieBio and SOSV - The Accelerator VC

i

indee labs (YC W17) raised $120K on March 20, 2017

Investors: Y Combinator and Bossa Nova Investimentos

FAQ